60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reiterated at Weiss Ratings
Weiss Ratings reiterated their sell (e+) rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Free Report) in a research report sent to investors on Saturday,Weiss Ratings reports. Separately, HC Wainwright restated a “neutral” rating on shares of 60 Degrees Pharmaceuticals in a report on Tuesday, February 25th. Get Our Latest Report on SXTP 60 […]
Weiss Ratings reiterated their sell (e+) rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Free Report) in a research report sent to investors on Saturday,Weiss Ratings reports. Separately, HC Wainwright restated a “neutral” rating on shares of 60 Degrees Pharmaceuticals in a report on Tuesday, February 25th. Get Our Latest Report on SXTP 60 […]
